These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7428639)

  • 21. [Decrease in the occurrence of transfusion hepatitis in Göttingen hospitals following the introduction of routine transaminase and Australia antigen determination in blood donors].
    Arndt HJ; Frese R; Nachtwey K; Loos W; Kaboth U; Creutzfeldt W
    Verh Dtsch Ges Inn Med; 1971; 77():1193-5. PubMed ID: 5155989
    [No Abstract]   [Full Text] [Related]  

  • 22. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on Au-SH-antigen positive blood donors].
    Krassnitzky O; Kail F; Pesendorfer F; Wewalka F
    Verh Dtsch Ges Inn Med; 1971; 77():1188-90. PubMed ID: 5155987
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatitis B vaccination of blood donors--a cost-benefit analysis.
    Gesemann M; Gentner P; Scheiermann N
    Beitr Infusionsther Transfusionsmed; 1994; 32():110-2. PubMed ID: 9422105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of hepatitis B and hepatitis C in blood donors and high risk groups in Hajjah, Yemen Republic.
    Haidar NA
    Saudi Med J; 2002 Sep; 23(9):1090-4. PubMed ID: 12370719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hepatitis B--significance for transfusion medicine].
    Jilg W
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():20-6. PubMed ID: 8000250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of AU-SH carriers in a blood donor population. Results by immunodiffusion, electrosyneresis and complement fixation test.
    Rosanda C; Giuliani G; Franchini MI; Tonda GP; Novara O
    Pathologica; 1971; 63(923):219-21. PubMed ID: 5005230
    [No Abstract]   [Full Text] [Related]  

  • 28. [Study of blood transaminases in blood donors in the prevention of post-transfusion virus hepatitis].
    Teofili T; Tucci G
    Ann Med Nav (Roma); 1969; 74(1):31-43 contd. PubMed ID: 5405058
    [No Abstract]   [Full Text] [Related]  

  • 29. [Determination of Au-SH antigens in the prevention of transfusion hepatitis].
    Fröhlich C
    Hippokrates; 1970 Sep; 41(3):408-9. PubMed ID: 5473623
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anti-HB-core antibodies as a surrogate marker in blood donors].
    Blejer JL; Saguier MC; Salamone HJ
    Sangre (Barc); 1999 Jun; 44(3):240-1. PubMed ID: 10481590
    [No Abstract]   [Full Text] [Related]  

  • 31. Occult hepatitis B virus infection among anti-HBc positive blood donors: Necessitates substitution of screening by HBV NAT.
    Panhotra BR; Bahrani A; Joshi CS; ul Hassan Z
    J Infect; 2005 Oct; 51(3):263. PubMed ID: 16125778
    [No Abstract]   [Full Text] [Related]  

  • 32. [Study about seroconversion of HBV NAT screening-positive crowd from blood donors].
    Wang DW; Wang TB; Liu FP; Shi LL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):127-9. PubMed ID: 18574536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus genotypes and precore mutations in Scottish blood donors.
    Davidson F; Lycett C; Sablon E; Petrik J; Dow BC
    Vox Sang; 2005 Feb; 88(2):87-92. PubMed ID: 15720605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positivity rate of hepatitis B surface antigen in 16-year-old first-time blood donors: effectiveness of immunoprophylaxis with hepatitis B vaccine and immunoglobulin in newborn infants with mothers positive for hepatitis B e antigen.
    Uchida S; Tadokoro K
    Jpn J Infect Dis; 2008 Jan; 61(1):94. PubMed ID: 18219148
    [No Abstract]   [Full Text] [Related]  

  • 35. AABB-CAP survey data on hepatitis--incidence, surveillance, and prevention.
    Polesky HF; Hanson M
    Am J Clin Pathol; 1980 Oct; 74(4 Suppl):565-8. PubMed ID: 7435449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Papua New Guinea Red Cross Blood Transfusion Service: present status and future considerations.
    Tozer RA
    P N G Med J; 1996 Mar; 39(1):38-42. PubMed ID: 9522849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trend study on HBsAg prevalence in Thai voluntary blood donors.
    Tanprasert S; Somjitta S
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():43-5. PubMed ID: 7886604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occult hepatitis B virus infection.
    Allain JP
    Transfus Clin Biol; 2004 Feb; 11(1):18-25. PubMed ID: 14980545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage.
    Yoshikawa A; Gotanda Y; Minegishi K; Taira R; Hino S; Tadokoro K; Ohnuma H; Miyakawa K; Tachibana K; Mizoguchi H;
    Transfusion; 2007 Jul; 47(7):1162-71. PubMed ID: 17581150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
    Manzini P; Girotto M; Borsotti R; Giachino O; Guaschino R; Lanteri M; Testa D; Ghiazza P; Vacchini M; Danielle F; Pizzi A; Valpreda C; Castagno F; Curti F; Magistroni P; Abate ML; Smedile A; Rizzetto M
    Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.